Ohcanbohtosat - Douglas G Altman

Aiddostahte ozu
  1. 1
    False Reassurance Based on Non-Significant Results

    False Reassurance Based on Non-Significant Results Dahkki Douglas G. Altman

    Almmustuhtton 2017-11-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Unjustified restrictions on letters to the editor.

    Unjustified restrictions on letters to the editor. Dahkki Douglas G Altman

    Almmustuhtton 2005-05-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals.

    Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. Dahkki Allison Hirst, Douglas G Altman

    Almmustuhtton 2012-01-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Four Proposals to Help Improve the Medical Research Literature.

    Four Proposals to Help Improve the Medical Research Literature. Dahkki David Moher, Douglas G Altman

    Almmustuhtton 2015-09-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.

    Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. Dahkki Peggy Sekula, Susan Mallett, Douglas G Altman, Willi Sauerbrei

    Almmustuhtton 2017-01-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Key issues in conducting a meta-analysis of gene expression microarray datasets.

    Key issues in conducting a meta-analysis of gene expression microarray datasets. Dahkki Adaikalavan Ramasamy, Adrian Mondry, Chris C Holmes, Douglas G Altman

    Almmustuhtton 2008-09-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

    CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Dahkki Kenneth F Schulz, Douglas G Altman, David Moher, CONSORT Group

    Almmustuhtton 2010-03-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Guidance for developers of health research reporting guidelines.

    Guidance for developers of health research reporting guidelines. Dahkki David Moher, Kenneth F Schulz, Iveta Simera, Douglas G Altman

    Almmustuhtton 2010-02-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Ítems de referencia para publicar Revisiones Sistemáticas y Metaanálisis: La Declaración PRISMA

    Ítems de referencia para publicar Revisiones Sistemáticas y Metaanálisis: La Declaración PRISMA Dahkki David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman, The PRISMA Group

    Almmustuhtton 2014-09-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

    Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Dahkki David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman, PRISMA Group

    Almmustuhtton 2009-07-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Epidemiology and reporting characteristics of systematic reviews.

    Epidemiology and reporting characteristics of systematic reviews. Dahkki David Moher, Jennifer Tetzlaff, Andrea C Tricco, Margaret Sampson, Douglas G Altman

    Almmustuhtton 2007-03-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Bland-Altman methods for comparing methods of measurement and response to criticisms

    Bland-Altman methods for comparing methods of measurement and response to criticisms Dahkki Mohammad Ali Mansournia, Rachel Waters, Maryam Nazemipour, Martin Bland, Douglas G. Altman

    Almmustuhtton 2021-11-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

    Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. Dahkki Douglas G Altman, Lisa M McShane, Willi Sauerbrei, Sheila E Taube

    Almmustuhtton 2012-01-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Guidelines for reporting health research: the EQUATOR network's survey of guideline authors.

    Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. Dahkki Iveta Simera, Douglas G Altman, David Moher, Kenneth F Schulz, John Hoey

    Almmustuhtton 2008-06-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

    Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Dahkki Carol Kilkenny, William J Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman

    Almmustuhtton 2010-06-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

    Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research Dahkki Carol Kilkenny, William J. Browne, Innes C. Cuthill, Michael Emerson, Douglas G. Altman

    Almmustuhtton 2014-02-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Uses and misuses of the STROBE statement: bibliographic study

    Uses and misuses of the STROBE statement: bibliographic study Dahkki Douglas G Altman, Matthias Egger, Bruno R da Costa, Anne W S Rutjes, Myriam Cevallos

    Almmustuhtton 2011-09-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers.

    Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers. Dahkki Darren Boone, Susan Mallett, Justine McQuillan, Stuart A Taylor, Douglas G Altman, Steve Halligan

    Almmustuhtton 2015-01-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository.

    Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository. Dahkki Catrin Tudur Smith, Kerry Dwan, Douglas G Altman, Mike Clarke, Richard Riley, Paula R Williamson

    Almmustuhtton 2014-01-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Ghost authorship in industry-initiated randomised trials.

    Ghost authorship in industry-initiated randomised trials. Dahkki Peter C Gøtzsche, Asbjørn Hróbjartsson, Helle Krogh Johansen, Mette T Haahr, Douglas G Altman, An-Wen Chan

    Almmustuhtton 2007-01-01
    Viečča ollesdeavstta
    Artihkal
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: